51 results
8-K
EX-99.1
RCUS
Arcus Biosciences Inc
21 Feb 24
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
4:08pm
to their respective owners.
Investor Inquiries:
Pia Eaves
Head of Investor Relations & Strategy
(617) 459-2006
peaves@arcusbio.com
Media Inquiries
8-K
EX-99.1
RCUS
Arcus Biosciences Inc
7 Nov 23
Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
4:04pm
owners.
Investor Inquiries:
Pia Eaves
Head of Investor Relations & Strategy
(617) 459-2006
peaves@arcusbio.com
Media Inquiries:
Holli Kolkey
VP
8-K
EX-99.1
5jz2c
7 Aug 23
Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
8:08am
8-K
EX-99.1
dhqumzb
9 May 23
Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
4:10pm
8-K
EX-99.1
vd9byzk8fu2r
2 Nov 22
Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
4:05pm
8-K
EX-99.1
1wgwhqeayzi97p1
3 Aug 22
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
4:16pm
8-K
EX-99.1
6vgvt108 ka0g00
9 May 22
Results of Operations and Financial Condition
4:08pm
8-K
EX-99.1
j8yml
23 Feb 22
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
4:08pm
8-K
EX-99.1
v9l9alka
8 Nov 21
Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
5:11pm